Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells.
Phosphorylation of glycogen synthase kinase-3 β at serine 9 confers cisplatin resistance in ovarian cancer cells
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study
PRELIMINARY-STUDY OF THE EFFECT OF SELECTED CHINESE NATURAL DRUGS ON HUMAN OVARIAN-CANCER CELLS